Stocks · News reference

Xylem shares are trading lower after the company announced an executive transition and affirmed its Q3 and FY26 sales guidance below analyst estimates.

Aug 18, 2026, 6:28 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

Zacks Investment ResearchAug 27, 2026, 3:30 PMNa
Xylem (XYL) Down 7.1% Since Last Earnings Report: Can It Rebound?
Xylem reported Q2 2026 adjusted earnings of $1.46 per share, beating consensus estimates by 9%, with revenues of $2.34 billion slightly exceeding expectations. The company raised its 2026 guidance with adjusted earnings now forecast at $5.55-$5.70 per share and EBITDA margin expansion of 90-130 basis points. However, shares have underperformed the S&P 500 by 7.1% since the earnings report, and analyst estimates have trended downward in the past month, resulting in a Zacks Rank #3 (Hold) rating.
Read original at zacks-investment-research
XYL
BenzingaAug 18, 2026, 2:56 PMBenzinga Newsdesk
Xylem Affirms FY2026 Adj EPS Guidance of $5.55-$5.70 vs $5.54 Est; Affirms FY2026 Sales Guidance of $9.200B vs $9.254B Est
Xylem (NYSE:XYL) affirms FY2026 Adj EPS guidance from $5.55-$5.70 to $5.55-$5.70 vs $5.54 analyst estimate. Affirms FY2026 sales outlook from $9.200 billion to $9.200 billion vs $9.254 billion estimate.
Read original at benzinga
XYL
BenzingaAug 18, 2026, 2:56 PMBenzinga Newsdesk
Xylem Affirms Q3 Adj EPS Guidance of $1.42-$1.47 vs $1.46 Est; Affirms Q3 Sales Guidance of $2.300B vs $2.316B Est
Xylem (NYSE:XYL) affirms Q3 Adj EPS guidance from $1.42-$1.47 to $1.42-$1.47 vs $1.46 analyst estimate. Affirms Q3 sales outlook from $2.300 billion to $2.300 billion vs $2.316 billion estimate.
Read original at benzinga
XYL